about
Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and societyPharmacogenetics in clinical practice: considerations for testing.Pharmacogenetics and ethical considerations: why care?Pharmacogenetics and Pharmacogenomics in Moderate-to-Severe Psoriasis.Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pharmacogenomics: questions and concerns.
@ast
Pharmacogenomics: questions and concerns.
@en
type
label
Pharmacogenomics: questions and concerns.
@ast
Pharmacogenomics: questions and concerns.
@en
prefLabel
Pharmacogenomics: questions and concerns.
@ast
Pharmacogenomics: questions and concerns.
@en
P356
P1476
Pharmacogenomics: questions and concerns.
@en
P304
P356
10.1185/030079905X50633
P407
P577
2005-07-01T00:00:00Z